参考文献/References:
[1] CANNON L,CAMPBELL M J,WU E Y.Multisystemic inflammatory syndrome in children and kawasaki disease:Parallels in pathogenesis and treatment[J].Curr Allergy Asthma Rep,2023,23(6):341-350.
[2] KABEERDOSS J,PILANIA R K,KARKHELE R,et al.Severe COVID-19,multisystem inflammatory syndrome in children,and kawasaki disease:Immunological mechanisms,clinical manifestations and management[J].Rheumatol Int,2021,41(1):19-32.
[3] 马平,刘崇海,唐庆,等.超声心动图分析冠状动脉损伤评估方法在川崎病冠状动脉病变的诊断价值[J].重庆医学,2023,52(11):1702-1706.
[4] 梁娟,马玉荣,韩娜,等.非对比增强全心冠状动脉磁共振血管成像在儿童川崎病冠状动脉病变中的应用[J].中国医学影像学杂志,2024,32(2):136-141.
[5] 韩丽杰,胡朝伟,于华惠,等.血管生成素样蛋白8在心血管疾病发病中作用的研究进展[J].基础医学与临床,2024,44(4):544-547.
[6] WANG J,HAN L N,AI D S,et al.Growth differentiation factor 15 predicts cardiovascular events in stable coronary artery disease[J].J Geriatr Cardiol,2023,20(7):527-537.
[7] MCCRINDLE B W,ROWLEY A H,NEWBURGER J W,et al.Diagnosis,treatment,and long-term management of kawasaki disease:A scientific statement for health professionals from the american heart association[J].Circulation,2017,135(17):927-999.
[8] 杨燕飞,吴玉芹,张兴.川崎病患儿心率变异性指标与冠状动脉病变的关系及其对后者的预测价值[J].中国医药,2020,15(12):1835-1839.
[9] 袁沛,池书彦,丁燕燕,等.川崎病患儿血清微小RNA-27a、过氧化物酶体增殖物激活受体γ水平与冠状动脉病变的关系[J].中国分子心脏病学杂志,2023,23(2):5293-5298.
[10] ZHANG Q Y,XU B W,DU J B.Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease:Clinical presentations,diagnosis,and treatment[J].World J Pediatr,2021,17(4):335-340.
[11] 胡慧敏,陈笑征,张永兰,等.川崎病急性期肝损害与冠状动脉损伤和免疫球蛋白无反应的关系[J].中国当代儿科杂志,2022,24(6):681-686.
[12] 刘杰.解毒化瘀汤联合丙种球蛋白治疗川崎病临床观察[J].陕西中医,2017,38(2):180-181.
[13] 王玉君,周莹.白虎汤治疗川崎病32例[J].陕西中医,2011,32(11):1458-1459.
[14] CHIDAMBARAM A C,RAMAMOORTHY J G,ANANTHARAJ A.Neutrophil-lymphocyte ratio for predicting coronary artery lesions in children with kawasaki disease[J].Indian Pediatr,2023,60(3):207-211.
[15] 刘娅,邝野,樊华,等.超声心动图、颈动脉内膜中层厚度联合N末端脑钠肽前体等指标对川崎病合并冠状动脉病变患儿诊断价值[J].临床军医杂志,2023,51(12):1281-1283,1287.
[16] 穆志龙,高颖,卫丽,等.热休克蛋白60、70在川崎病冠状动脉病变中的表达及意义[J].陕西医学杂志,2020,49(9):1117-1120.
[17] HAMMAD M M,CHANNANATH A M,ABU-FARHA M,et al.Adolescent obesity and ANGPTL8:Correlations with high sensitivity C-reactive protein,leptin,and chemerin[J].Front Endocrinol(Lausanne),2023,14(1):1314211-1314212.
[18] MORINAGA J,KASHIWABARA K,TORIGOE D,et al.Plasma ANGPTL8 levels and risk for secondary cardiovascular events in iapanese patients with stable coronary artery disease receiving statin therapy[J].Arterioscler Thromb Vasc Biol,2023,43(8):1549-1559.
[19] 宋思育,何廉旗,胡庆薇,等.血清Lp-PLA2和ANGPTL8水平对冠心病及冠状动脉病变程度的诊断价值研究[J].重庆医学,2023,52(16):2459-2464.
[20] FADAEI R,SHATERI H,DISTEFANO J K,et al.Higher circulating levels of ANGPTL8 are associated with body mass index,triglycerides,and endothelial dysfunction in patients with coronary artery disease[J].Mol Cell Biochem,2020,469(1-2):29-39.
[21] ROYSTON L,ISNARD S,PERRIN N,et al.Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque:Value in people living with and without HIV[J].Front Cardiovasc Med,2022,9(1):964650-964651.
[22] 梁小弟,梁小菊,李芙蓉,等.生长分化因子-15在白细胞介素-1β诱导软骨细胞凋亡与炎症中的作用及潜在机制[J].陕西医学杂志,2021,50(3):280-284.
[23] 张曦月,杨源瑞,何楠,等.老年冠心病病人血清MCP-1、GDF-15、GMP-140与冠状动脉狭窄程度的相关性[J].中西医结合心脑血管病杂志,2024,22(6):1068-1071.
[24] WANG J,ZHANG T,XU F,et al.GDF-15 at admission predicts cardiovascular death,heart failure,and bleeding outcomes in patients with CAD[J].ESC Heart Fail,2023,10(5):3123-3132.
[25] AN H S,KIM G B,SONG M K,et al.The occurrence of coronary artery lesions in kawasaki disease based on C-reactive protein levels:A retrospective cohort study[J].Pediatr Rheumatol Online J,2021,19(1):78-79.
相似文献/References:
[1]孙春晖,乐 原.川崎病合并冠状动脉病变患儿前白蛋白、胱抑素C、血小板四项变化及临床意义[J].陕西医学杂志,2021,50(12):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
SUN Chunhui,LE Yuan.Changes and clinical significance of prealbumin,cystatin C and four parameters of platelet in Kawasaki disease children with coronary arterial lesions[J].,2021,50(3):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
[2]严晓华,王 娜,马 娟,等.阿托伐他汀对小鼠川崎病的治疗作用及机制研究[J].陕西医学杂志,2022,51(6):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
YAN Xiaohua,WANG Na,MA Juan,et al.Therapeutic effect and mechanism of atorvastatin on Kawasaki disease mice[J].,2022,51(3):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
[3]寇志军,李 静,马亨曼,等.川崎病患儿心血管病变易感性与血清N末端B型脑钠肽原、前白蛋白及C-反应蛋白表达水平相关性研究[J].陕西医学杂志,2022,51(6):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
KOU Zhijun,LI Jing,MA Hengman,et al.Correlation between cardiovascular disease susceptibility and serum levels of NT-proBNP,PA and CRP in children with Kawasaki disease[J].,2022,51(3):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
[4]赵 萌,杨轶童,李翰文,等.肠道微生物菌群与川崎病关系研究进展[J].陕西医学杂志,2024,(2):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
ZHAO Meng,YANG Yitong,LI Hanwen,et al.Research progress on relationship between gut microbiota and Kawasaki disease[J].,2024,(3):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
[5]左玮玮,郭泓江.颈动脉CTA评估颈动脉粥样硬化狭窄程度及与血清脂蛋白相关磷脂酶A2、血管生成素样蛋白8水平的相关性分析[J].陕西医学杂志,2025,54(1):62.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.011]
ZUO Weiwei,GUO Hongjiang.Carotid artery CTA assessed the degree of carotid atherosclerosis stenosis and its correlation with serum Lp-PLA2 and ANCPTL8 levels[J].,2025,54(3):62.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.011]
[6]杨 敏,刘 鑫.血清可溶性肿瘤坏死因子受体Ⅱ/Ⅰ比值、白细胞介素-17联合心电图诊断川崎病患儿急性期冠状动脉损伤的价值[J].陕西医学杂志,2025,54(3):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]
YANG Min,LIU Xin.Value of serum sTNFR Ⅱ/Ⅰ,IL-17 combined with ECG in diagnosis of coronary artery injury in children with Kawasaki disease in acute phase[J].,2025,54(3):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]